Page 1110 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1110

Chapter 80







                     REFERENCES

                       1. Peters CJ, Zaki SR. Overview of viral hemorrhagic fevers. In:     17. Effler PV, Pang L, Kitsutani P, et al. Dengue Fever, Hawaii,
                        Guerrant  RL,  Walker  DH,  Weller  PF,  eds.  Tropical Infectious   2001–2002. Emerg Inf Dis. 2005;11:742-749.
                        Diseases: Principles, Pathogens and Practice. 3rd ed. London:     18. Easterbrook JD, Kaplan JB, Vanasco NB, et al. A survey of zoo-
                        Elsevier Health Sciences; 2011.                         notic pathogens carried by Norway rats in Baltimore, Maryland,
                       2. Bausch DG, Peters CJ. The viral hemorrhagic fevers. In: Lutwick LI,     USA. Epidemiol Infect. 2007;135:1192-1199.
                        Lutwick SM, eds. Beyond Anthrax. Springer Science + Business     19. Khabbaz RF, Ksiaszek TG, Caiaffa WT, et al. Seoul Hantavirus
                        Media, LLC; 2008:107-143.                               seropositivity among injecting drug users in Baltimore. J Infect
                       3. Meltzer E, Schwartz E. A travel medicine view of dengue and   Dis. 1994;170:1636-1637.
                        dengue hemorrhagic fever. Trav Med Inf Dis. 2009;7:278-283.    20. Roig IL, Musher DM, Tweardy DJ. Severe pulmonary involve-
                       4. Mohammed HP, Ramos MM, Rivera A, et al. Travel-associated   ment in a case attributed to domestically acquired Seoul hanta-
                        dengue infections in the United States, 1996 to 2005. J Trav Med.   virus in the United States. Clin Infect Dis. 2012:54:91-94.
                        2010;17:8-14.                                        21. Barry M, Russi M, Armstrong L, et al. Treatment of a laboratory-
                       5. Sotir MJ, Johnson DK, Davis JP. Travel-associated dengue   acquired Sabiá virus infection.  N Engl J Med. 1995;333:
                        illness  among  Wisconsin  residents.  Wisconsin Med J.  2009;   294-296.
                        108(9):447-452.                                      22. World Health Organization. Outbreaks in laboratory person-
                       6. Wichmann O, Gascon J, Schunk M, et al. Severe dengue virus   nel working with Cercopithecus monkeys from East Africa—
                        infection in travelers: risk factors and laboratory indicators. J Inf   Europe. Wkly Epidemiol Rec. 1967;42:479-480.
                        Dis. 2007;195:1089-1096.                             23. Hartley DM, Rinderknecht JL, Nipp TL, Clarke NP, Snowder
                       7. Bulugahapitiya U, Siyambalapitiya S, Seveviratne SL, et al.   GD; National Center for Foreign Animal and Zoonotic Disease
                        Dengue fever in travelers: a challenge for European physicians.   Defense Advisory Group. Potential effects of Rift Valley fever in
                        Europ J Intern Med. 2007;18:185-192.                    the United States. Emerg Infect Dis. August 2011. http://dx.doi.
                       8. Barnett ED. Yellow fever: epidemiology and prevention. Clin Inf   org/10.3201/eid1708.101088. Accessed October 20, 2014.
                        Dis. 2007;44:850-856.                                24. Pigott  DC.  Hemorrhagic  fever  viruses.  Critic Care Clin.
                       9. Monath TP, Cetron MS. Prevention of yellow fever in persons   2005;21:765-783.
                        traveling to the tropics. Clin Infect Dis. 2002;34:1369-1378.    25. Guzman MG, Kouri G. Dengue diagnosis, advances and chal-
                      10. Amorosa V, MacNeil A, McConnell R, et al. Imported Lassa fever,   lenges. Internat J Inf Dis. 2004;8:69-80.
                        Pennsylvania, USA, 2010. Emerg Inf Dis. 2010;16:1598-1600.    26. Gubler DJ. Dengue and dengue hemorrhagic fever.  Clin
                      11. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa fever in   Microbiol Rev. 1998;11(3):480-496.
                        Germany: surveillance and management of contact persons.     27. Ramos MM, Mohammed H, Zielinski-Gutierrez E, et al.
                        Clin Inf Dis. 2003;36:1254-1258.                        Epidemic dengue and dengue hemorrhagic fever at the Texas–
                      12. Holmes GP, McCormick JB, Trock SC, et al. Lassa fever in the   Mexico border: results of a household-based seroepidemiologic
                        United States. N Engl J Med. 1990;323(16):1120-1123.    survey, December 2005. Am J Trop Med Hyg. 2008;78(3):364-369.
                      13. Macher AM, Wolfe MS. Historical Lassa fever reports and     28. Tomashek KM, Margolis HS. Dengue: a potential transfusion-
                        30-year clinical update. Emerg Inf Dis. 2006;12:835-837.  transmitted disease. Transfusion. 2011;51:1654-1660.
                      14. Fujita N, Miller A, Miller G, et al. Imported case of Marburg hem-    29. Carroll  ID,  Toovey  S,  Van  Gompel  A.  Dengue  fever  and
                        orrhagic fever— Colorado, 2008. MMWR. 2009;58:1377-1381.  pregnancy: a review and comment.  Travel Med Infect Dis.
                      15. Timen A, Koopmans MPG, Vossen ACTM, et al. Response to   2007;5:183-188.
                        imported case of Marburg hemorrhagic fever, the Netherlands.     30. Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine.
                        Emerg Inf Dis. 2009;15:1171-1175.                       2011;29:7221-7228.
                      16. Trout A, Baracco G, Rodriguez M. Locally acquired dengue—     31. Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue.
                        Key West, Florida, 2009–2010. MMWR. 2010;59(19):577-581.  N Engl J Med. 2012;366:1423-1432.









            Section05-O-ref.indd   1                                                                                   1/20/2015   4:51:25 PM
   1105   1106   1107   1108   1109   1110   1111   1112   1113   1114   1115